Management of Elevated Liver Enzymes and Leukocytosis

Initial Evaluation and Pattern Recognition

The American Gastroenterological Association recommends determining the pattern of liver enzyme elevation (hepatocellular vs. cholestatic) and performing a comprehensive liver etiology workup to identify treatable causes, and simultaneously investigating the leukocytosis to rule out infectious, inflammatory, or malignant processes that may be driving both abnormalities 1, 2
A hepatocellular pattern is suggested by a predominant ALT/AST elevation, with an ALT:AST ratio >1 indicating non-alcoholic causes and an AST:ALT ratio >1 indicating alcoholic liver disease 2, 3
The European Association for the Study of the Liver recommends categorizing the severity of elevation as mild to moderate (<3× upper limit of normal (ULN)) or severe (>3× ULN) 2, 3
Marked elevation (>1000 U/L) may indicate acute viral hepatitis 1, 2

The American College of Gastroenterology recommends obtaining a medication review, including all prescribed drugs, over-the-counter medications, herbal supplements, and illicit drugs, as many can cause both hepatotoxicity and leukocytosis 1, 2, 3
A thorough history should include alcohol consumption, viral hepatitis risk factors, metabolic syndrome features, autoimmune history, recent infections or travel, and symptoms such as jaundice, abdominal pain, weight loss, pruritus, and fever 1, 2, 3
The physical examination should focus on calculating body mass index, abdominal examination for hepatosplenomegaly, ascites, and signs of chronic liver disease, and looking for stigmata of cirrhosis such as spider angiomata and palmar erythema 1, 2

The World Gastroenterology Organisation recommends ordering a comprehensive laboratory panel, including complete blood count with differential, comprehensive metabolic panel, complete liver function tests, inflammatory markers, viral hepatitis screen, autoimmune markers, and iron studies 4, 2, 3
Abdominal ultrasound should be obtained immediately to assess liver parenchyma, biliary tract, and hepatosplenomegaly 1, 2, 5
MRI/MRCP should be considered if there is a cholestatic pattern with a history of IBD or autoimmune disease to evaluate for primary sclerosing cholangitis 1, 2, 5

The American Association for the Study of Liver Diseases recommends referring patients to hepatology immediately if there is evidence of synthetic dysfunction, dilated bile ducts on imaging, or imaging suggesting advanced fibrosis, cirrhosis, or focal lesions 1, 2, 3
Urgent referral criteria include ALT >8× ULN or >5× baseline, ALT >3× ULN with total bilirubin >2× ULN, and persistent elevation >2× ULN after 3 months despite addressing modifiable factors 2, 3
The European Association for the Study of the Liver recommends monitoring liver enzymes every 3-6 months initially for identified chronic liver disease, and annual monitoring for complications 5, 3